NCT03371836View on ClinicalTrials.gov

Use of Clobazam for Epilepsy and Anxiety

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
EpilepsyAnxiety
Interventions
DRUG

Clobazam

Clobazam is used as an adjunct medicine for all participants.

Trial Locations (1)

21205

Kennedy Krieger Institute, Baltimore

All Listed Sponsors
lead

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER

NCT03371836 - Use of Clobazam for Epilepsy and Anxiety | Biotech Hunter | Biotech Hunter